These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29 related articles for article (PubMed ID: 1981362)
1. [Basic and clinical studies of neuropeptide-producing carcinoma]. Saito H; Sano T Nihon Naibunpi Gakkai Zasshi; 1990 Dec; 66(12):1248-54. PubMed ID: 1981362 [No Abstract] [Full Text] [Related]
2. Neuroendocrinomas and neuroendocrine carcinomas: APUD cell system neoplasms and their aberrant secretory activities. Gould VE Pathol Annu; 1977; 12 Pt 2():33-62. PubMed ID: 202912 [No Abstract] [Full Text] [Related]
3. [ACTH-ectopic syndrome]. Britvin TA; Kalinin AP Klin Med (Mosk); 2003; 81(9):8-13. PubMed ID: 14598583 [No Abstract] [Full Text] [Related]
4. Secretion of chromogranin A by peptide-producing endocrine neoplasms. O'Connor DT; Deftos LJ N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986 [TBL] [Abstract][Full Text] [Related]
5. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors. Saito H; Saito S Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747 [TBL] [Abstract][Full Text] [Related]
6. Coexistence of somatostatin-immunoreactivity in an adrenal pheochromocytoma and a thyroid medullary carcinoma (Sipple syndrome). Bethge N; Ahuja S; Diel F; Usadel KH Exp Clin Endocrinol; 1988 May; 91(2):217-22. PubMed ID: 2900771 [TBL] [Abstract][Full Text] [Related]
7. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors. Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172 [TBL] [Abstract][Full Text] [Related]
11. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583 [TBL] [Abstract][Full Text] [Related]
12. Hypothalamic releasing factors for ACTH and growth hormone: two newly discovered peptides with a promising future in clinical medicine. Ontjes DA; Underwood LE N C Med J; 1984 Jan; 45(1):9-13. PubMed ID: 6422311 [No Abstract] [Full Text] [Related]
13. [Sipple syndrome (bilateral phaeochromocytoma medullary C-cell carcinoma of the thyroid gland) with exceptionally prolonged clinical course]. Kovarik J; Silberbauer K; Woloszczuk W; Krisch K; Geyer G Wien Klin Wochenschr; 1982 Jun; 94(13):340-5. PubMed ID: 6127842 [TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of medullary carcinoma of the thyroid. Block MA Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281 [TBL] [Abstract][Full Text] [Related]
16. Melanin-producing medullary carcinoma of the thyroid gland. Eng HL; Chen WJ Arch Pathol Lab Med; 1989 Apr; 113(4):377-80. PubMed ID: 2705868 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults. Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029 [TBL] [Abstract][Full Text] [Related]
19. The role of somatostatin analogues in the treatment of neuroendocrine tumours. Grozinsky-Glasberg S; Grossman AB; Korbonits M Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561 [TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma and hypercalcemia due to ectopic production of parathyroid hormone. Garbini A; Mainardi M; Grimi M; Repaci G; Nanni G; Bragherio G N Y State J Med; 1986 Jan; 86(1):25-7. PubMed ID: 3456508 [No Abstract] [Full Text] [Related] [Next] [New Search]